2.5 ML sodium hyaluronate 10 MG/ML Prefilled Syringe [Supartz]
RxNorm concept 1721082, branded drug (sbd). Prescribable name: SUPARTZ FX 25 MG in 2.5 ML Prefilled Syringe.
- RxCUI
- 1721082
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1721082 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
2.5 ML Supartz 10 MG/ML Prefilled Syringe; Supartz 25 MG per 2.5 ML Prefilled Syringe
Related concepts
- sodium hyaluronate 10 MG/ML (SCDC, consists of)
- sodium hyaluronate 10 MG/ML [Supartz] (SBDC, consists of)
- Prefilled Syringe (DF, has dose form)
- Supartz (BN, has ingredient)
- 2.5 ML sodium hyaluronate 10 MG/ML Prefilled Syringe (SCD, tradename of)
Linked data
NDCs
- 89130444401
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1721082 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1721082 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1721082. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.